CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company
CERENOME, INC.
Sign in to watch- Ticker
- CNSY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330827593
- Phone
- 737.255.7194
- Business address
- 6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
- Former names
- PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
- 8-K Event Material agreement · Regulation FD disclosure
- 4/A Derivatives Options or other derivatives
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Open-market buy Chief Financial Officer bought 2,000 shares at $1.10 ($2,200)
- 8-K Event Results of operations
- 10-K Report Annual Report
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Regulation FD disclosure · Other events
- 4 Open-market buy Chief Financial Officer bought 1,000 shares at $1.86 ($1,864)
- 4 Open-market buy Director bought 12,500 shares at $1.72 ($21,500)
- 4 Open-market buy Chief Executive Officer bought 2,500 shares at $1.66 ($4,150)
- 4 Open-market buy Chief Financial Officer bought 2,000 shares at $1.67 ($3,339)
- 8-K Event Results of operations
Page 16 of 74 · 1,465 filings